Microbix Biosystems Inc. MBX
TSX · Canada · Health Technology
CAD 0.31000.00 (0.00%)
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Meetings with Growth-Oriented Investors, September 25 to 27, 2026MISSISSAUGA, ON / ACCESS Newswire / September 23, 2026 / (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Event, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 25 to 27, 2025.
MISSISSAUGA, ON / ACCESS Newswire / September 9, 2026 / (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has completed formal qualification to become a supplier for five in-vitro diagnostics (IVD) manufacturers ("Dx Test-Makers"). Each of these five Dx Test-Makers are considered to be one of the ten largest such companies by revenues, and Microbix is pleased to have successfully completed their supplier audit & quality review processes.
Microbix Biosystems Inc (MBXBF) reports robust growth in antigen and CAPS sales, improved profitability metrics, and strategic progress in its Kinlytic program despite ongoing net losses.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.